|
|
|
Attention-Deficit Hyperactivity Disorder Clinical Trials, Diagnosis, and |
|
Thank you for your interest in clinical trials for
Attention-Deficit Hyperactivity Disorder.
Please click "Search" to find Attention-Deficit Hyperactivity Disorder clinical
trials and medical research studies or read below for information on
Attention-Deficit Hyperactivity Disorder diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 13 studies:
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 191 studies:
- A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT00700427-66206
Conditions: Attention Deficit Hyperactivity Disorder
Location: Prairie Village, KS
- A Phase I/IIa, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Safety, and Efficacy of SPN-812V in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - NCT01107496-
Conditions: ADHD
Location: Herndon, VA
- ADHD Smoking Cessation Study - NCT00736255-27705
Conditions: Attention Deficit Hyperactivity Disorder - Nicotine Dependence
Location: Durham, NC
- An In Depth Cardiovascular Study of Lisdexamfetamine (LDX; Vyvanse) in Healthy and Treated Hypertensive Adults With Attention Deficit Hyperactivity Disorder (ADHD) - NCT00753012-02138
Conditions: Attention Deficit/Hyperactivity Disorder(ADHD)
Location: Cambridge, MA
- An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD - NCT00302380-02138
Conditions: Attention Deficit Hyperactivity Disorder
Location: Cambridge, MA
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD - NCT00417794-73117
Conditions: Fetal Alcohol Syndrome - Attention Deficit Disorder With Hyperactivity (ADHD) - Attention Deficit Disorder (ADD)
Location: Oklahoma City, OK
- Bupropion for ADHD in Adolescents With Substance Use Disorder - NCT00936299-80210
Conditions: Attention Deficit Hyperactivity Disorder - Nicotine Dependence - Cannabis Use Disorder
Location: Denver, CO
- Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study - NCT00830700-98105
Conditions: Attention Deficit Disorder With Hyperactivity
Location: Seattle, WA
- Classroom-Level Intervention to Promote Peers' Acceptance of Children With Attention Deficit Hyperactivity Disorder (ADHD) - NCT01133028-22904
Conditions: Attention Deficit Hyperactivity Disorder
Location: Charlottesville, VA
- Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01137318-11367
Conditions: ADHD
Location: Flushing, NY
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Tom's River, NJ
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-20852
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Rockville, MD
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-27707
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Durham, NC
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-30060
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Marietta, GA
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-32607
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Gainesville, FL
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-33013
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Hialeah, FL
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-42003
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Paducah, KY
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-47802
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Terre Haute, IN
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-58104
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Fargo, ND
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-63301
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: St. Charles, MO
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-73103
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Oklahoma City, OK
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-77090
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Houston, TX
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-78247
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: San Antonia, TX
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-79423
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Lubbock, TX
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-92108
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: San Diego, CA
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-92595
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Wildomar, CA
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate - NCT01106430-98033
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Kirkland, WA
- Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials - NCT01063153-02138
Conditions: Attention Deficit Hyperactivity Disorder
Location: Cambridge, MA
- Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? - NCT01127607-33199
Conditions: ADHD
Location: Miami, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-02114
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Boston, MA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-08755
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Toms River, NJ
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-19139
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Philadelphia, PA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-20170
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Herndon, VA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-20852
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Rockville, MD
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-23230
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Richmond, VA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-27707
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Durham, NC
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-30060
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Marietta, GA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-32216
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Jacksonville, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-32607
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Gainesville, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-32806
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Orlando, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-33013
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Hialeah, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-33143
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: South Miami, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-34208
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Bradenton, FL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-36303
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Dothan, AL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-38119
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Memphis, TN
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-42003
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Paducah, KY
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-46260
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Indianapolis, IN
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-47802
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Terre Haute, IN
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-48307
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Rochester Hills, MI
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-60048
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Libertyville, IL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-60563
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Naperville, IL
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-64114
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Kansas City, MO
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-66211
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Overland Park, KS
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-72205
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Little Rock, AR
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-75115
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: DeSoto, TX
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-78247
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: San Antonio, TX
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-78756
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Austin, TX
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-79423
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Lubbock, TX
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-89128
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Las Vegas, NV
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-90274
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Rolling Hills Estates, CA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-92108
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: San Diego, CA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-92595
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Wildomar, CA
- Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl - NCT01081132-98004
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Bellevue, WA
- Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17 - NCT00784654-23112
Conditions: ADHD
Location: Overland Park, KS
- Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17 - NCT00784654-38119
Conditions: ADHD
Location: Memphis, TN
- Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17 - NCT00784654-47802
Conditions: ADHD
Location: South Miami, FL
- Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17 - NCT00784654-66212
Conditions: ADHD
Location: Rolling Hills Estates, CA
- Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents - NCT00252278-02903
Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD) - Insomnia
Location: Providence, RI
- Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia - NCT01156051-08619
Conditions: Attention-Deficit/Hyperactivity Disorder - Attention Deficit Disorder - Insomnia - Sleep Disorders
Location: Hamilton, NJ
- Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia - NCT01156051-08755
Conditions: Attention-Deficit/Hyperactivity Disorder - Attention Deficit Disorder - Insomnia - Sleep Disorders
Location: Toms River, NJ
- Effectiveness of ATMX in Treating Adolescents With ADHD and SUD - NCT00218322-02114
Conditions: Attention Deficit Disorder With Hyperactivity - Substance-Related Disorders
Location: Boston, MA
- Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism - NCT00498173-46202
Conditions: Autism
Location: Indianapolis, IN
- Effects of Atomoxetine on Brain Activation During Attention and Reading Tasks in Patients With ADHD & Comorbid Dyslexia - NCT00716274-06520
Conditions: Attention Deficit Hyperactivity Disorder - Dyslexia
Location: New Haven, CT
- Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD) - NCT01124721-95825
Conditions: ADHD - Attention
Location: Sacramento, CA
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-05401
Conditions: ADHD
Location: Burlington, VT
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-08046
Conditions: ADHD
Location: Willingboro, NJ
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-19139
Conditions: ADHD
Location: Philadelphia, PA
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-30308
Conditions: ADHD
Location: Atlanta, GA
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-32216
Conditions: ADHD
Location: Jacksonville, FL
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-32751
Conditions: ADHD
Location: Maitland, FL
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-32806
Conditions: ADHD
Location: Orlando, FL
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-33161
Conditions: ADHD
Location: North Miami, FL
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-33319
Conditions: ADHD
Location: Lauderhill, FL
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-34208
Conditions: ADHD
Location: Bradenton, FL
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-38119
Conditions: ADHD
Location: Memphis, TN
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-44718
Conditions: ADHD
Location: Canton, OH
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-45417
Conditions: ADHD
Location: Dayton, OH
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-77007
Conditions: ADHD
Location: Houston, TX
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-77008
Conditions: ADHD
Location: Houston, TX
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-78756
Conditions: ADHD
Location: Austin, TX
- Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) - NCT01124708-97210
Conditions: ADHD
Location: Portland, OR
- Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) - NCT01069523-78229
Conditions: Attention Deficit Disorder With Hyperactivity
Location: San Antonio, TX
- Enhancing ADHD Driving Performance With Stimulant Medication - NCT00572026-22908
Conditions: Attention Deficit Hyperactivity Disorder
Location: Charlottesville, VA
- Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care - NCT01143701-43205
Conditions: ADHD
Location: Columbus, OH
- Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta - NCT00181792-02138
Conditions: ADHD - Smoking
Location: Cambridge, MA
- Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) - NCT00046059-20892
Conditions: Attention Deficit Disorder With Hyperactivity
Location: Bethesda, MD
- Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) - NCT00046059-92668
Conditions: Attention Deficit Disorder With Hyperactivity
Location: Orange, CA
- Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder - NCT00879320-02138
Conditions: ADHD - Attention Deficit Hyperactivity Disorder
Location: Cambridge, MA
- Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) - NCT00867451-45229
Conditions: Attention Deficit Hyperactivity Disorder
Location: Cincinnati, OH
- Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine - NCT01146002-07450
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Ridgewood, NJ
- Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children - NCT00754208-68198
Conditions: Attention Deficit Hyperactivity Disorder
Location: Omaha, NE
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-10029
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: New York, NY
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-19139
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Philadelphia, PA
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-21801
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Salisbury, MD
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-23230
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Richmond, VA
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-27707
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Durham, NC
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-32216
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Jacksonville, FL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-32607
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Gainesville, FL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-32751
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Maitland, FL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-32806
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Orlando, FL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-33013
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Hialeah, FL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-34208
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Brandenton, FL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-36303
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Dothan, AL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-43210
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Columbus, OH
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-46260
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Indianapolis, IN
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-60563
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Naperville, IL
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-68198
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Omaha, NE
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-70114
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: New Orleans, LA
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-72205
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Little Rock, AR
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-73103
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Oklahoma City, OK
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-78247
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: San Antonio, TX
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-78756
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Austin, TX
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-89128
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Las Vegas, NV
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-92108
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: San Diego, CA
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-92595
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Widowmar, CA
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-97301
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Salem, OR
- Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) - NCT01081145-98033
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Kirkland, WA
- Metabolic Effects of Antipsychotics in Children - NCT00205699-63110
Conditions: Aggression - ADHD - Oppositional Defiant Disorder - PDD - Bipolar Disorder
Location: St. Louis, MO
- Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence - NCT00672256-27705
Conditions: Smoking - ADHD
Location: Durham, NC
- Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD) - NCT01123668-27705
Conditions: Smoking - ADHD
Location: Durham, NC
- Neuroimaging of the Effects of Concerta in the Treatment of ADHD - NCT00778310-78229
Conditions: Attention Deficit Disorder With Hyperactivity
Location: San Antonio, TX
- Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth - NCT01109849-33199
Conditions: ADHD - Growth
Location: Miami, FL
- Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD - NCT00418262-73117
Conditions: Fetal Alcohol Syndrome - Attention Deficit Disorder (ADD) - Attention Deficit Disorder With Hyperactivity (ADHD)
Location: Oklahoma City, OK
- Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD) - NCT01176136-45229
Conditions: Attention Deficit Hyperactivity Disorder
Location: Cincinnati, OH
- Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager - NCT00644566-10021
Conditions: ADHD
Location: New York, NY
- Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager - NCT00644566-11106
Conditions: ADHD
Location: Long Island City, NY
- Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse - NCT00573534-10034
Conditions: Attention Deficit Hyperactivity Disorder
Location: New York, NY
- Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta - NCT00181714-02138
Conditions: ADHD
Location: Cambridge, MA
- Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence - NCT00553319-10032
Conditions: Adult Attention Deficit Hyperactivity Disorder - Cocaine Dependence
Location: New York, NY
- Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence - NCT00553319-55454
Conditions: Adult Attention Deficit Hyperactivity Disorder - Cocaine Dependence
Location: Minneapolis, MN
- Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS) - NCT00181857-02138
Conditions: ADHD
Location: Cambridge, MA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-
Conditions: ADHD Specifically With Executive Function Impairment
Location: Cherry Hill, NJ
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-05091
Conditions: ADHD Specifically With Executive Function Impairment
Location: Woodstock, VT
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-05401
Conditions: ADHD Specifically With Executive Function Impairment
Location: Burlington, VT
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-10016
Conditions: ADHD Specifically With Executive Function Impairment
Location: New York, NY
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-10549
Conditions: ADHD Specifically With Executive Function Impairment
Location: Mount Kisco, NY
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-20170
Conditions: ADHD Specifically With Executive Function Impairment
Location: Herndon, VA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-20852
Conditions: ADHD Specifically With Executive Function Impairment
Location: Rockville, MD
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-27609
Conditions: ADHD Specifically With Executive Function Impairment
Location: Raleigh, NC
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-27707
Conditions: ADHD Specifically With Executive Function Impairment
Location: Durham, NC
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-30060
Conditions: ADHD Specifically With Executive Function Impairment
Location: Marietta, GA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-30308
Conditions: ADHD Specifically With Executive Function Impairment
Location: Atlanta, GA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-32250
Conditions: ADHD Specifically With Executive Function Impairment
Location: Jacksonville Beach, FL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-32751
Conditions: ADHD Specifically With Executive Function Impairment
Location: Maitland, FL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-32806
Conditions: ADHD Specifically With Executive Function Impairment
Location: Orlando, FL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-33407
Conditions: ADHD Specifically With Executive Function Impairment
Location: West Palm Beach, FL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-33912
Conditions: ADHD Specifically With Executive Function Impairment
Location: Fort Myers, FL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-34208
Conditions: ADHD Specifically With Executive Function Impairment
Location: Bradenton, FL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-42003
Conditions: ADHD Specifically With Executive Function Impairment
Location: Paducah, KY
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-48307
Conditions: ADHD Specifically With Executive Function Impairment
Location: Rochester Hills, MI
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-49686
Conditions: ADHD Specifically With Executive Function Impairment
Location: Traverse City, MI
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-53562
Conditions: ADHD Specifically With Executive Function Impairment
Location: Middleton, WI
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-60048
Conditions: ADHD Specifically With Executive Function Impairment
Location: Libertyville, IL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-60563
Conditions: ADHD Specifically With Executive Function Impairment
Location: Naperville, IL
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-63301
Conditions: ADHD Specifically With Executive Function Impairment
Location: St. Charles, MO
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-66211A
Conditions: ADHD Specifically With Executive Function Impairment
Location: Overland Park, KS
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-66211B
Conditions: ADHD Specifically With Executive Function Impairment
Location: Overland Park, KS
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-72205
Conditions: ADHD Specifically With Executive Function Impairment
Location: Little Rock, AR
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-77007
Conditions: ADHD Specifically With Executive Function Impairment
Location: Houston, TX
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-77090
Conditions: ADHD Specifically With Executive Function Impairment
Location: Houston, TX
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-78756
Conditions: ADHD Specifically With Executive Function Impairment
Location: Austin, TX
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-79423
Conditions: ADHD Specifically With Executive Function Impairment
Location: Lubbock, TX
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-89128
Conditions: ADHD Specifically With Executive Function Impairment
Location: Las Vegas, NV
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-90274
Conditions: ADHD Specifically With Executive Function Impairment
Location: Rolling Hills Estates, CA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-92108
Conditions: ADHD Specifically With Executive Function Impairment
Location: San Diego, CA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-97210
Conditions: ADHD Specifically With Executive Function Impairment
Location: Portland, OR
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-97301
Conditions: ADHD Specifically With Executive Function Impairment
Location: Salem, OR
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-98033
Conditions: ADHD Specifically With Executive Function Impairment
Location: Kirkland, WA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-98104
Conditions: ADHD Specifically With Executive Function Impairment
Location: Seattle, WA
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) - NCT01101022-99202
Conditions: ADHD Specifically With Executive Function Impairment
Location: Spokane, WA
- Screening Protocol for Adults With ADHD - NCT00592254-02138
Conditions: ADHD
Location: Cambridge, MA
- Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder - NCT00592436-02138
Conditions: Pediatric ADHD
Location: Cambridge, MA
- Skills Training for Adolescents With ADHD - NCT01019252-02114
Conditions: Attention Deficit Hyperactivity Disorder
Location: Boston, MA
- Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD) - NCT00989950-65807
Conditions: Attention Deficit Hyperactivity Disorder - Insomnia
Location: Springfield, MO
- The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents - NCT00566371-02903
Conditions: Attention Deficit Hyperactivity Disorder - Insomnia
Location: Providence, RI
- The Effect of Guanfacine Extended-release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia - NCT01153178-08619
Conditions: Attention Deficit Hyperactivity Disorder - Attention Deficit Disorder - Insomnia - Sleep Disorders
Location: Hamilton, NJ
- The Effect of Guanfacine Extended-release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia - NCT01153178-08755
Conditions: Attention Deficit Hyperactivity Disorder - Attention Deficit Disorder - Insomnia - Sleep Disorders
Location: Toms River, NJ
- Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate - NCT00931398-15213
Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Location: Pittsburgh, PA
- Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth - NCT01107301-55455
Conditions: ADHD
Location: Minneapolis, MN
- Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity - NCT01017263-27705
Conditions: Attention Deficit Hyperactivity Disorder - Glucose Intolerance - Obesity
Location: Durham, NC
- Vyvanse Driving Study - NCT00801229-02138
Conditions: Attention Deficit/Hyperactivity Disorder(ADHD)
Location: Cambridge, MA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|